Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

NCT05382637 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Growth Disorders

Interventions

DRUG: Somatropin

Sponsor

Children's National Research Institute